Notification of Major Interest by Legal & General9th November 2016 - 5:57 pm
ImmuPharma PLC (LSE:IMM) (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc (“L&G”) confirming its holding in ImmuPharma of 4,285,714 million Ordinary Shares in the capital of the Company, representing 3.43% of ImmuPharma’s total voting rights.
Commenting, Tim McCarthy, Chairman of ImmuPharma, said: “We are delighted to be able to disclose Legal & General as one of the new significant and major institutional investors which participated in ImmuPharma’s recent successful vendor placing. One of the Board’s priorities is to maintain and strengthen our shareholder base. We are therefore delighted that such a highly regarded institution as Legal & General has demonstrated its support for ImmuPharma.”